Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-069220
Filing Date
2023-03-13
Accepted
2023-03-13 17:27:35
Documents
5
Effectiveness Date
2023-03-13

Document Format Files

Seq Description Document Type Size
1 S-8 d481666ds8.htm S-8 31418
2 EX-5.1 d481666dex51.htm EX-5.1 6277
3 EX-23.1 d481666dex231.htm EX-23.1 1340
4 EX-FILING FEES d481666dexfilingfees.htm EX-FILING FEES 21715
5 GRAPHIC g481666g0311091326729.jpg GRAPHIC 2644
  Complete submission text file 0001193125-23-069220.txt   65526
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270509 | Film No.: 23728318
SIC: 2834 Pharmaceutical Preparations